Search
Menu
Charles River Laboratories Completes the Acquisition of Cognate BioServices

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed...

Find Out More
Charles River Laboratories Completes the Acquisition of Cognate BioServices
INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development

INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development

Thomas Moore, Science and Medical Correspondent Sky News, is joined by Prof. Lindy Durrant, immunologist and joint CEO/CSO of Scancell, and Alex...

Find Out More
INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

Providing large scale manufacturing capacity for AZD1222

Find Out More
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

Our Awards

Breaking the Mould Company of the Year 2020
QE
BioNow
CMO
CMO
CMO
SCB Awards 2017
TS Business Awards

Get In Touch

Speak to a member of our expert Advanced Therapies team and arrange to take a tour of our GMP facilities in the UK and Sweden.

Request a Callback
Get In Touch

About Cobra Biologics

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.

2 GMP approved facilities
320+ products released for clinical trials
20+ Countries serviced